Home / Drug shortages / Fosaprepitant Dimeglumine Injection

Fosaprepitant Dimeglumine Injection — FDA Drug Shortage

To Be Discontinued — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Fosaprepitant Dimeglumine Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on 04/08/2026.

Shortage Details

Status
To Be Discontinued
Company
Fresenius Kabi USA, LLC
Package NDC
63323-972-10
Dosage Form
Injection
Presentation
Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)
Initial Posting
04/08/2026
Revised Date

FDA data resources